Key takeaways:
Retatrutide is an investigational medication researchers are studying for weight loss and other health conditions. It isn’t FDA approved or available in the market.
Products advertised online as retatrutide, compounded retatrutide, or research-use only retatrutide are not approved by the FDA. Their contents, quality, and safety may be unknown.
Eli Lilly, retatrutide’s manufacturer, plans to apply for FDA approval in early 2027. It’s possible that retatrutide could be approved later that year.
Retatrutide — an injectable medication sometimes called “reta” online — has attracted a lot of media and public attention, even though it isn’t available yet. This is because promising clinical trial results have increased interest in its potential for weight loss.
At the same time, knock-off products claiming to contain retatrutide have appeared for sale online. But there’s no reliable way to confirm what these products contain or how they’re made. There have even been reports of these products potentially being linked to two deaths.
Thinking about buying retatrutide online? Here’s how to understand the claims sellers make and what to do if you’ve already purchased or used one of these products.
What is retatrutide?
Retatrutide is an investigational, once-weekly injectable medication developed by Eli Lilly. It activates three hormone binding sites: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon. Because of this, it’s sometimes called a “triple agonist.”
Through these actions, retatrutide may:
Help the pancreas release insulin when blood glucose (sugar) is elevated
Reduce sugar production in the liver
Slow the movement of food out of the stomach
Lessen appetite and increase feelings of fullness
Increase the amount of energy the body uses
Researchers are studying retatrutide for weight loss, Type 2 diabetes, and other health conditions. So far, results have been promising but research is still ongoing.
Is retatrutide FDA approved?
No, retatrutide isn’t currently FDA approved for any use and isn’t available in the market.
But Eli Lilly plans to submit an application to the FDA during the first quarter of 2027. The FDA will then decide if the available evidence supports approval. Based on this timeline, it’s possible that retatrutide could be approved at some point in 2027.
What does ‘counterfeit retatrutide’ mean?
A counterfeit medication is made or labeled to look like an authentic product. It may contain the wrong ingredient, an incorrect amount of an ingredient, or no active ingredient at all. It may also contain harmful contaminants.
In the case of retatrutide, there’s no FDA-approved commercial product for a seller to copy. Products marketed as “retatrutide” may be fake, illegally marketed, or otherwise unsafe. Even if testing suggests that a product contains retatrutide, it would still be an unapproved medication made outside of Eli Lilly’s clinical trial program.
Why are fake and unapproved retatrutide products concerning?
The biggest concern with fake and unapproved retatrutide products is that you may not know what you’re buying or injecting. That creates several risks, including:
These products haven’t undergone FDA review. Unapproved drug products haven’t gone through FDA review to determine that they work, are safe, and meet certain quality standards.
The contents of these products may not match the label. Products may contain the wrong ingredient, an unexpected amount, or no retatrutide at all. For example, other countries have found counterfeit retatrutide that contained semaglutide (the active ingredient in Wegovy and Ozempic) instead — in amounts 8 times higher than commercially-available medications.
Quality and sterility may be uncertain. Products may contain impurities, heavy metals, and other contaminants.
The dosage instructions may be unreliable. There’s no FDA-approved retatrutide dosage or prescribing information. Instructions provided by a seller aren’t a substitute for an FDA-reviewed medication label.
Some products aren’t intended for people to use. The FDA has also warned of companies selling people unapproved retatrutide products labeled “for research-use only” or “not for human consumption.”
Can you buy real retatrutide online?
Retatrutide is still in development, and is currently available only to eligible participants in authorized clinical trials or expanded access programs. So “real” retatrutide is not available to buy online, from a pharmacy, or through a telehealth service.
Currently, any retatrutide product sold directly to people is unapproved. This remains true even if:
A healthcare professional prescribes it
It’s a compounded product from a pharmacy
The website displays a certificate of analysis
The label says it was tested by an independent laboratory
The product is described as “research grade” or “for research purposes”
Keep in mind that a certificate or laboratory report may not be authentic. And even legitimate testing of one sample doesn’t guarantee that every vial has the same contents, potency, or purity.
Can retatrutide be compounded?
No, the FDA has stated that retatrutide can’t be used in compounding under federal law. This is because retatrutide isn’t used in an FDA-approved medication or included in recognized standards or federal lists for compounding.
Plus, there’s another potential barrier: retatrutide could be regulated as a biologic. Because of its structure and molecule size, Eli Lilly plans to seek approval through a biologic license application. Federal law doesn’t allow biologics to be compounded.
Compounded medications, which are custom-made medications by compounding pharmacies, can meet important medical needs in certain situations. But their ingredients must still meet federal compounding requirements, and retatrutide doesn’t qualify.
How can you recognize fake or unapproved retatrutide?
Any retatrutide product currently offered for sale is unapproved. With that in mind, you don’t need to determine whether the product is “real” before deciding not to use it. Even so, common warning signs include:
The product is sold through social media, an online marketplace, or a peptide website.
It’s advertised as “reta,” “GLP-3,” or another alternative name.
The label says “research-use only” or “not for human consumption.”
The seller calls it compounded, generic, or equivalent to the retatrutide used in clinical trials.
It comes as a powder that must be mixed with bacteriostatic water before injection.
No prescription or medical screening is required.
The website promises unusually fast results or offers prices that seem too good to be true.
The label has spelling mistakes, missing instructions, or pharmacy information that can’t be verified.
What should you do if you bought or used fake retatrutide?
If you bought a product claiming to contain retatrutide, it’s best not to inject or use it. If you’ve already used it, don’t take another dose without talking to a healthcare professional.
Take the following steps:
Contact a healthcare professional or Poison Control. Tell them what and how much you used, when you used it, and whether you’re experiencing side effects. You can reach Poison Control by calling 1-800-222-1222.
Get emergency help for severe symptoms. Call 911 for trouble breathing, a seizure, loss of consciousness, or other life-threatening reactions.
Keep the product information. Save the packaging, label, receipt, and any messages from the seller. These details may help your healthcare team or the FDA identify the product.
Report the product to the FDA. You can report side effects and quality problems through MedWatch. You can also report a website that may be selling retatrutide illegally.
If you’re interested in retatrutide, ask your healthcare professional if you may qualify for a clinical trial or expanded access program. They can also discuss similar FDA-approved weight-loss medications that may be appropriate for you now.
The bottom line
Retatrutide is an investigational medication that isn’t FDA approved or available for purchase. Any product sold as retatrutide outside an authorized clinical trial or expanded access program is unapproved. It may also contain unknown ingredients or have quality problems.
The FDA could approve retatrutide as early as sometime in 2027. If you’re interested in trying retatrutide, speak with a healthcare professional before buying it online. They can help you understand your options, including participating in a clinical trial or trying an alternative treatment until it’s available.
Why trust our experts?


References
Gilbert, D. (2026). Two deaths were reported to the FDA. Is the bootleg weight-loss drug "Reta" to blame? CBS News.
Hailu, K. T., et al. (2026). Unregulated peptide use in the age of biohacking: Digital promotion, gray-market access, and emerging public health risks. Cureus.
Katsi, V., et al. (2025). Retatrutide—a game changer in obesity pharmacotherapy. Biomolecules.
Lilly. (n.d.). Expanded access.
Lilly. (2026). Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market.
Lilly. (2026). Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C. PR Newswire.
Lilly. (2026). What to know about retatrutide: An investigational triple hormone receptor agonist.
The Partnership for Safe Medicines. (n.d.). The retatrutide black market: Patient safety groups warn of growing risks from understudied drugs.
Therapeutic Goods Administration. (2026). TGA tests counterfeit retatrutide product following serious adverse event report. Australian Department of Health, Disability and Ageing.
U.S. Food and Drug Administration. (2025). Compounding and the FDA: Questions and answers.
U.S. Food and Drug Administration. (2026). Bulk drug substances used in compounding.
U.S. Food and Drug Administration. (2026). FDA’s concerns with unapproved GLP-1 drugs used for weight loss.










